/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
New Digital Advocacy Research Shows Connections Between Citizens and Policymakers Up 38% in 2018
Phone2Action’s Inaugural State of Advocacy Report Examines How
Grassroots Advocacy Movements are Built and What Mobilizes Supporters to
Act
WASHINGTON–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/advocacy?src=hash” target=”_blank”gt;#advocacylt;/agt;–Citizens are engaging in issue advocacy and reaching out to their
lawmakers more than ever before, according to new research from
Phone2Action, a digital advocacy platform that connects citizens to
lawmakers.
Released today, Phone2Action’s first State of Advocacy report reviewed
anonymized, aggregated data from hundreds of nonprofit organizations,
associations, and companies that use the Phone2Action platform,
examining how some of the most successful advocacy movements of the past
year were able to build momentum, transform passive supporters into
engaged advocates, and ultimately change policy on the local, state and
federal level.
“By text, email, calls and social media, citizens are actively engaging
with their lawmakers at an unprecedented rate, sparking important
conversations and fully engaging in the democratic process,” said Jeb
Ory, Phone2Action CEO. “Lawmakers want – and need – to hear
constituents’ stories and opinions and the more we as an industry can do
to increase the efficiency of that communication, the better.”
The report focuses on insights and data points related to how digital
tools like Facebook, SMS campaigns and Twitter have impacted issue
advocacy in recent years.
Key findings include:
-
Advocacy engagement continues to rise. The total number of
interactions between advocates and decision-makers increased 36% in
2017 and 38% in 2018 -
Digital advocacy tools are helping boost the rate of advocate
acquisition. Out of all advocates acquired over the past three years,
40% of them were acquired in 2018, compared to 35% in 2017 and 25% in
2016. -
Most organizations acquire advocates via text messaging. 69% of
advocates acquired in 2018 were acquired via SMS Keyword campaigns,
20% via Facebook Lead Ads and 11% via social media (Facebook and
Twitter). -
Connections between advocates and regulatory agencies (e.g., EPA, FCC)
increased 700% between 2016 and 2018. Regulatory bodies interpret how
to implement new and existing laws and offer an alternative way for
organizations to influence policy. -
Connections between citizens and local lawmakers increased threefold
from 2017 to 2018 as organizations hyper-focused on local legislation
to have an immediate impact on their communities. -
There was a dramatic increase in patch-through advocacy-related calls
following the 2016 election. In 2017, advocates made 542% more
patch-through calls to lawmakers than they did in 2016. This number
remained fairly steady in 2018.
The report also offers actionable takeaways that organizations can
easily implement in their own digital advocacy campaigns. For example:
-
SMS is a more effective engagement medium when supporters are being
asked to sign a petition than when they are asked to contact their
legislator -
SMS digital advocacy campaigns are best executed Tuesday through
Thursday
Phone2Action is offering a free webinar that explores its research
findings on Thursday, May 23 at 1pm Eastern (register here).
To download a free copy of the State of Advocacy report, visit https://phone2action.com/resource/the-state-of-advocacy.
Methodology:
Phone2Action examined anonymized, aggregated advocacy data from
nonprofit organizations, associations, and companies that used the
Phone2Action platform in 2018 and a sub-sample of 260 organizations that
used the platform over the past three years. The usage data originates
from organizations’ activity within the platform, such as creating
campaigns, and from advocates taking action through the platform, such
as signing a petition or contacting a legislator.
About Phone2Action
Phone2Action, founded by Ximena Hartsock and Jeb Ory, is a comprehensive
digital advocacy and communications platform that directly powers social
movements by connecting users to lawmakers via technology. For more
information, please visit: www.phone2action.com.
Contacts
Media Contact:
Jennefer Traeger
Traeger Communications
720-988-6149
[email protected]
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
transfer
IMC to transfer its Oranim Pharmacy shares back to the seller
TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.
“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”
About IM Cannabis Corp.
IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.
The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.
Disclaimer for Forward-Looking Statements
This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, the occurrence of growth opportunities and the likelihood of growth potential.
Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.
The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East
Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.
The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Company Contacts:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]
Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]
Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html
Cannabis
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Avant2 weeks ago
Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market
-
StickIt2 weeks ago
StickIt Technologies Inc. Announces Year-End 2023 Financial Results
-
Cannabis1 week ago
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
-
Cannabis1 week ago
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
-
Cannabis1 week ago
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
-
Cannabis1 week ago
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
-
Cannabis1 week ago
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
-
Cannabis1 week ago
Geopulse Exploration, Inc. Acquires 50% of ATC Services